New camera aims to spot stomach and bowel diseases without a biopsy
NCT ID NCT04565704
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing a new optical imaging device that takes pictures of tissue samples from the stomach and colon during routine endoscopy. The goal is to see if the device can detect signs of disease without needing to remove tissue for a traditional biopsy. Researchers will compare the images to standard lab results to see if the device works well enough for future use. The study involves 200 adults already scheduled for an endoscopy or colonoscopy.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Optical imaging device
- What this could lead to
- If successful, this could lead to a non-invasive tool that helps doctors diagnose gastrointestinal diseases more quickly and accurately during routine endoscopy.
- What could go wrong
- This is an early feasibility study with only 200 participants, so the device may not work as hoped or may not be better than current methods. It is not yet tested for treatment or cure.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 200 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Mar 2016
- Expected to finish
-
Dec 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: • Scheduled for an elective esophagoduodenoscopy and/or colonoscopy Exclusion Criteria: • According to standard of care at MGH endoscopy department.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Gastrointestinal disease are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a $50 water filter keep appalachian families out of the bathroom?
- Acupoint injection may ease gut troubles in ventilated patients
- Could poop transplants save sepsis patients?
- New painkiller aims to prevent gut woes after brain surgery
- Poop pills for ICU patients? new trial tests fecal transplants for feeding troubles
- New study tracks gut health and confusion in malnourished cancer surgery patients